C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
- PMID: 27134035
- DOI: 10.1016/j.brainres.2016.04.062
C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Abstract
A hexanucleotide (G4C2) repeat expansion in the 5' non-coding region C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Three modes of toxicity have been proposed: gain of function through formation of RNA foci and sequestration of RNA binding proteins; expression of dipeptide repeat proteins generated by repeat-associated non-ATG translation; and loss of function due to C9orf72 haploinsufficiency. Much is known about the proposed gain of function mechanisms, but there is little knowledge of the normal function of C9orf72 and the cellular consequences if its activity is perturbed. Here we will review what is known of C9orf72 at the transcript and protein levels and how changes in C9orf72 expression could contribute to disease pathogenesis. This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.
Keywords: ALS/FTLD; C9-isoforms; C9-transcripts; C9orf72; Hexanucleotide repeat expansion.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Neurobiol Aging. 2014 Oct;35(10):2421.e1-2421.e12. doi: 10.1016/j.neurobiolaging.2014.04.015. Epub 2014 Apr 19. Neurobiol Aging. 2014. PMID: 24836899 Review.
-
Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.Acta Neuropathol. 2014 Mar;127(3):377-89. doi: 10.1007/s00401-013-1235-1. Epub 2013 Dec 24. Acta Neuropathol. 2014. PMID: 24366528 Review.
-
Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.Neurobiol Aging. 2014 Jul;35(7):1779.e5-1779.e13. doi: 10.1016/j.neurobiolaging.2014.01.016. Epub 2014 Jan 17. Neurobiol Aging. 2014. PMID: 24559645 Free PMC article.
-
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.Trends Neurosci. 2013 Aug;36(8):450-9. doi: 10.1016/j.tins.2013.04.010. Epub 2013 Jun 7. Trends Neurosci. 2013. PMID: 23746459 Review.
-
Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72.J Neurogenet. 2015;29(2-3):85-94. doi: 10.3109/01677063.2015.1085980. J Neurogenet. 2015. PMID: 26540641 Review.
Cited by
-
Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.Mol Neurobiol. 2017 Aug;54(6):4466-4476. doi: 10.1007/s12035-016-9993-0. Epub 2016 Jun 28. Mol Neurobiol. 2017. PMID: 27349438 Review.
-
C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A.NAR Mol Med. 2024 Nov 12;1(4):ugae019. doi: 10.1093/narmme/ugae019. eCollection 2024 Oct. NAR Mol Med. 2024. PMID: 39669124 Free PMC article.
-
C9ORF72: What It Is, What It Does, and Why It Matters.Front Cell Neurosci. 2021 May 5;15:661447. doi: 10.3389/fncel.2021.661447. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34025358 Free PMC article. Review.
-
Editorial: Molecular mechanisms underlying C9orf72 neurodegeneration, volume II.Front Cell Neurosci. 2024 Jan 8;17:1357319. doi: 10.3389/fncel.2023.1357319. eCollection 2023. Front Cell Neurosci. 2024. PMID: 38259506 Free PMC article. No abstract available.
-
Therapeutic Approaches for C9ORF72-Related ALS: Current Strategies and Future Horizons.Int J Mol Sci. 2025 Jun 28;26(13):6268. doi: 10.3390/ijms26136268. Int J Mol Sci. 2025. PMID: 40650046 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous